The Joker’s deck: factors triggering the aggressive behavior on a patient with a pseudobulbar affect

  • Estefany Viana-Vivanco
    Universidad Marista de Mérida nmendez[at]marista.edu.mx
  • Andrés Alejandro Flores-Pereira
    Universidad Marista de Mérida
  • Alberto Alvarez-Baeza
    Universidad Marista de Mérida
  • Reinhard Janssen-Aguilar
    Universidad Marista de Mérida
  • Nina I. Méndez-Domínguez
    Universidad Marista de Mérida

Abstract

The plot of the Joker shows us the emergence of the antihero from Arthur, an individual with a pseudobulbar disorder, a history of abandonment and severe physical abuse and abuse with probable brain trauma, living without social ties, lacking affection, as a primary caregiver of a relative dependent entirely on him; the protagonist moves in an adverse, hostile environment in which the society that expects him to behave as if he had no disorder. normal behavior. «Without resources and rejected by its means, it is collaterally affected by the reduction of budget for therapy and medications. At a decisive moment, the different triggers of his psychopathological manifestations converge that give way to the transformation of the joker and paradoxically lead him to be socially accepted. Joker invites us to reflect on the importance of mental health programs, human values, the culture of Peace and good treatment as fundamental pillars to promote mental health in society. This article aims to revisit the pathophysiology of the pseudobulbar condition and establish the clinical, family, environmental and sociocultural aspects potentially associated with Joker’s destructive behavior.
  • Referencias
  • Cómo citar
  • Del mismo autor
  • Métricas
Ahmed A, Simmons Z. Pseudobulbar affect: prevalence and management. Ther Clin Risk Manag. 2013;9:483-9.

Allen J, Balfour R, Bell R, Marmot M. Social determinants of mental health. Int Rev Psychiatry. 2014;26(4):392-407.

Catala-Lopez F, Ridao M. Cost-effectiveness analyses in neuropsychiatry and mental health. Actas Esp Psiquiatr. 2017;45(3):127-36.

Chang YD, Davis MP, Smith J, Gutgsell T. Pseudobulbar Affect or Depression in Dementia? J Pain Symptom Manage. 2016;51(5):954-8.

Chen JJ. Pharmacotherapeutic management of pseudobulbar affect. Am J Manag Care. 2017;23(18 Suppl):S345-s50.

Crumpacker DW. Enhancing Approaches to the Identification and Management of Pseudobulbar Affect. J Clin Psychiatry. 2016;77(9):e1155.

Dalgleish T. Cognitive approaches to posttraumatic stress disorder: the evolution of multirepresentational theorizing. Psychol Bull. 2004;130(2):228-60.

Danesh HB. Creating a culture of healing in multiethnic communities: an integrative approach to prevention and amelioration of violence-induced conditions. J Community Psychol. 2008;36(6):814-32.

Demler TL. Introduction to pseudobulbar affect: setting the stage for recognition and familiarity with this challenging disorder. Am J Manag Care. 2017;23(18 Suppl):S339-s44.

Goodman AM, Harnett NG, Wheelock MD, Hurst DR, Orem TR, Gossett EW et al. Anticipatory prefrontal cortex activity underlies stress-induced changes in Pavlovian fear conditioning. NeuroImage. 2018;174:237-47.

Gruebner O, Rapp MA, Adli M, Kluge U, Galea S, Heinz A. Cities and Mental Health. Dtsch Arztebl Int. 2017;114(8):121-7.

Gutiérrez-García A, Calvo MG. Social anxiety and threat-related interpretation of dynamic facial expressions: sensitivity and response bias. Pers Indiv Differ. 2017 Mar 1;107:10-6.

Johnston DA, Harvey SB, Glozier N, Calvo RA, Christensen H, Deady M. The relationship between depression symptoms, absenteeism and presenteeism. J Affect Disord. 2019 ;256:536-40.

Miller A, Pratt H, Schiffer RB. Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments. Expert Rev Neurother. 2011;11(7):1077-88.

Mitra R, Jadhav S, McEwen BS, Vyas A, Chattarji S. Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala. Proc Natl Acad Sci U S A. 2005;102(26):9371-6.

Quarracino C, Garreto NS, Arakaki T, Franco A, González L, Morera NB, et al. Frecuencia de afección seudobulbar en pacientes con esclerosis lateral amiotrófica, enfermedad de Parkinson, esclerosis múltiple y accidente cerebrovascular. Neurol Arg. 2014;6(3):142-8.

Sauve WM. Recognizing and treating pseudobulbar affect. CNS Spectr. 2016;21(S1):34-44.

Strowd RE, Cartwright MS, Okun MS, Haq I, Siddiqui MS. Pseudobulbar affect: prevalence and quality of life impact in movement disorders. J Neurol. 2010; 257(8):1382-7.

Vargas T, Ahmed AO, Strauss GP, Brandes CM, Walker EF, Buchanan RW, et al. The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness. Transl Psychiatry. 2019;9(1):229.

Velásquez NR. Análisis de la relación entre la salud mental y el malestar humano en el trabajo. Equidad Desarro. 2017(29):161-78.

Work SS, Colamonico JA, Bradley WG, Kaye RE. Pseudobulbar affect: an under-recognized and under-treated neurological disorder. Adv Ther. 2011;28(7):586-601.

Xu M, Li Z, Ding C, Zhang J, Fan L, Diao L, et al. The Divergent Effects of Fear and Disgust on Inhibitory Control: An ERP Study. PLoS One. 2015;10(6):e0128932.
Viana-Vivanco, E., Flores-Pereira, A. A., Alvarez-Baeza, A., Janssen-Aguilar, R., & Méndez-Domínguez, N. I. (2020). The Joker’s deck: factors triggering the aggressive behavior on a patient with a pseudobulbar affect. Journal of Medicine and Movies, 16(3), 165–174. https://doi.org/10.14201/rmc2020163165174

Most read articles by the same author(s)

Downloads

Download data is not yet available.
+